Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Apr 24  •  04:00PM ET
11.10
Dollar change
-0.10
Percentage change
-0.89
%
Index
RUT
P/E
-
EPS (ttm)
-0.76
Insider Own
11.57%
Shs Outstand
41.68M
Perf Week
2.21%
Market Cap
458.64M
Forward P/E
-
EPS next Y
-0.16
Insider Trans
0.00%
Shs Float
36.54M
Perf Month
-1.07%
Enterprise Value
432.22M
PEG
-
EPS next Q
-0.09
Inst Own
93.84%
Perf Quarter
6.94%
Income
-31.39M
P/S
1.46
EPS this Y
-6.67%
Inst Trans
-1.29%
Perf Half Y
-8.57%
Sales
313.73M
P/B
2.67
EPS next Y
2.08%
ROA
-11.50%
Perf YTD
-13.55%
Book/sh
4.16
P/C
12.13
EPS next 5Y
41.52%
ROE
-17.47%
52W High
13.99 -20.66%
Perf Year
15.15%
Cash/sh
0.92
P/FCF
-
EPS past 3/5Y
-6.93% 28.31%
ROIC
-17.15%
52W Low
8.36 32.78%
Perf 3Y
26.57%
Dividend Est.
-
EV/EBITDA
157.74
Sales past 3/5Y
-2.57% 2.06%
Gross Margin
50.93%
Volatility
2.94% 4.85%
Perf 5Y
-55.72%
Dividend TTM
-
EV/Sales
1.38
EPS Y/Y TTM
25.37%
Oper. Margin
-6.52%
ATR (14)
0.45
Perf 10Y
-10.77%
Dividend Ex-Date
-
Quick Ratio
1.47
Sales Y/Y TTM
10.73%
Profit Margin
-10.00%
RSI (14)
55.83
Dividend Gr. 3/5Y
- -
Current Ratio
2.35
EPS Q/Q
-80.17%
SMA20
4.57%
Beta
0.40
Payout
-
Debt/Eq
0.07
Sales Q/Q
8.91%
SMA50
2.41%
Rel Volume
0.54
Prev Close
11.20
Employees
675
LT Debt/Eq
0.06
SMA200
1.31%
Avg Volume
440.43K
Price
11.10
IPO
May 27, 2004
Option/Short
Yes / Yes
Trades
Volume
237,652
Change
-0.89%
Date Action Analyst Rating Change Price Target Change
Jul-16-25Initiated Lake Street Buy $24
Apr-05-24Upgrade Oppenheimer Perform → Outperform $12
Sep-25-23Initiated H.C. Wainwright Buy $19
Apr-17-23Downgrade Raymond James Strong Buy → Outperform $14 → $13
Oct-15-21Upgrade Canaccord Genuity Hold → Buy $28 → $37
Aug-20-21Initiated Oppenheimer Perform
Nov-25-20Upgrade Raymond James Mkt Perform → Strong Buy $18
Apr-08-20Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Apr-01-19Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Apr-03-18Upgrade Raymond James Mkt Perform → Outperform
Apr-10-26 08:11PM
Apr-02-26 03:00PM
12:41PM
06:11AM
06:00AM
08:00AM Loading…
Mar-31-26 08:00AM
Mar-19-26 08:00AM
Mar-05-26 01:00PM
09:31AM
Mar-02-26 08:25AM
Feb-27-26 12:43PM
09:40AM
Feb-25-26 11:50AM
Feb-23-26 04:30PM
12:42PM
08:30AM Loading…
Feb-19-26 08:30AM
Feb-16-26 08:54AM
Feb-13-26 01:11PM
12:35PM
Feb-06-26 09:55AM
Feb-05-26 11:30AM
08:00AM
Feb-04-26 12:51PM
Feb-03-26 08:00AM
Jan-30-26 09:55AM
Jan-29-26 12:47PM
Jan-14-26 07:04PM
10:13AM
Jan-13-26 01:40PM
Jan-12-26 09:35AM
12:11PM Loading…
Jan-07-26 12:11PM
Jan-06-26 02:00PM
11:24AM
09:27AM
09:03AM
06:00AM
Dec-24-25 12:29PM
Dec-23-25 08:00AM
Dec-22-25 08:00AM
Nov-21-25 10:50AM
Oct-27-25 04:30PM
Oct-26-25 06:16AM
Oct-13-25 08:30AM
Oct-03-25 12:47PM
08:21AM
Oct-02-25 03:01PM
12:28PM
07:10AM
06:08AM
06:00AM
Oct-01-25 09:15AM
Sep-22-25 12:27PM
Sep-18-25 08:00AM
Sep-09-25 06:45PM
Aug-28-25 11:30AM
Aug-21-25 01:30PM
Aug-14-25 04:04AM
Aug-06-25 04:30PM
Jul-28-25 08:30AM
Jul-25-25 11:13AM
Jul-23-25 08:30AM
Jul-18-25 07:02AM
Jul-16-25 12:35PM
03:03AM
Jul-15-25 04:42PM
07:40AM
06:44AM
06:30AM
Jul-14-25 09:18AM
Jul-07-25 08:00AM
Jun-26-25 10:55AM
08:23AM
Jun-24-25 10:43AM
Jun-23-25 08:00AM
Jun-20-25 11:40AM
11:36AM
Jun-18-25 09:55AM
09:52AM
Jun-17-25 11:39AM
Jun-16-25 11:14AM
Jun-13-25 12:37PM
Jun-11-25 10:28AM
Jun-09-25 11:55AM
11:35AM
Jun-06-25 12:26PM
09:41AM
Jun-05-25 12:07PM
Jun-04-25 12:31PM
12:26PM
12:00PM
Jun-03-25 12:10PM
Jun-02-25 08:38AM
May-30-25 10:14AM
09:40AM
May-29-25 10:08AM
10:06AM
09:31AM
May-28-25 11:50AM
11:47AM
09:22AM
AngioDynamics, Inc. is a medical device company, which engages in the development, manufacturing, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The firm offers ablation systems, fluid management systems, vascular access, angiographic, drainage, thrombolytic, and venous products. It operates through the Med Tech and Med Device segments. The Med Tech segment consists of technology portfolio including Auryon, the thrombus management platform and NanoKnife. The Med Device segment focuses on core, venous, ports, and other oncology products. The company was founded by Howard S. Stern and Eamonn P. Hobbs on February 9, 1988 and is headquartered in Latham, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Weiss Lawrence TSVP, Chief Legal OfficerOct 21 '25Buy11.8110,000118,10093,597Oct 22 07:00 AM
Trowbridge Stephen AEVP and CFOOct 13 '25Buy11.168909,932256,629Oct 14 06:11 AM
Clemmer James CPresident and CEOOct 09 '25Buy11.1510,000111,500882,529Oct 09 09:09 PM